C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2006
11/09/2006	US20060251658 Antibodies to TGF-beta
11/09/2006	US20060251655 Antibody against enzyme specifically cleaving von villebrand factor and assay system using the same
11/09/2006	US20060251648 Nucleotide sequences coding transport protein for use in identifying modulators for treatment of pain; flavor enhancement
11/09/2006	US20060251647 Quantitating the level of Apo-2 receptor expression in a biological sample to determine whether a patient has a disorder associated with an abnormal rate of apoptotic cell death
11/09/2006	US20060251646 Anti-tirc7 antibodies in therapy of inflammatiory diseases
11/09/2006	US20060251645 Humanized immunoglobulin reactive with B7-2 and methods of treatment therewith
11/09/2006	US20060251644 or an antigen binding fragment comprising variable light chain region and heavy chain peptides, directed against isotypic determinants of immunoglobulin E (IgE), useful for diagnostics, prophylaxis and treatment of disease such as asthma, rhinitis, eczema, urticaria. dermatitis or food allergies
11/09/2006	US20060251643 Regulatory zinc finger proteins
11/09/2006	US20060251636 Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
11/09/2006	US20060251635 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
11/09/2006	US20060251619 Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides
11/09/2006	US20060251604 Method for diagnosing alopecia
11/09/2006	CA2606876A1 Fluorescent proteins and uses thereof
11/09/2006	CA2606489A1 Method for identification of compound having antidepressant effect
11/09/2006	CA2606450A1 Anti-platelet membrane glycoprotein vi monoclonal antibody
11/09/2006	CA2606008A1 Combination therapy in the treatment of cancer
11/08/2006	EP1719779A2 Antibodies against Matin
11/08/2006	EP1718977A1 Protein phosphorylation in t-cell receptor signaling pathways
11/08/2006	EP1718976A1 Protein phosphorylation in anaplastic large cell lymphoma
11/08/2006	EP1718760A1 Protein phosphorylation in c-src signaling pathways
11/08/2006	EP1718753A2 Methods for making and using molecular switches involving circular permutation
11/08/2006	EP1718752A1 A novel hansenula polymorpha gene coding for alpha 1,6-mannosyltransferase and process for the production of recombinant glycoproteins with hansenula polymorpha mutant strain deficient in the same
11/08/2006	EP1718677A2 Monovalent antibody fragments useful as therapeutics
11/08/2006	EP1718664A2 Modified human four helical bundle polypeptides and their uses
11/08/2006	EP1718339A2 Modified human interferon polypeptides and their uses
11/08/2006	EP1678315A4 Engineered zinc finger proteins for regulation of gene expression
11/08/2006	EP1636360A4 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
11/08/2006	EP1558725A4 High expression locus vector based on ferritin heavy chain gene locus
11/08/2006	EP1237930B1 Chimeric amyloid beta peptides
11/08/2006	CN1860226A Method of cleaving polypeptide by using OmpT protease mutant
11/08/2006	CN1859925A Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity
11/08/2006	CN1858230A Process for preparing oligomeric peptide capable of inhibiting angiotonase activity
11/08/2006	CN1858229A Process for preparing oligomeric peptide capable of clearing superoxide anion
11/08/2006	CN1858228A Process for preparing low molecular peptide and amino acid by biological enzymolysis of pig blood haematoglobin
11/08/2006	CN1858227A Process for preparing biological active peptide for improving lactic acid bacteria proliferation and fermentation to produce acid
11/08/2006	CN1858226A Method for preparing water soluble wheat protein by composite modifying
11/08/2006	CN1858225A Process for preparing bird's nest polypeptide and use
11/08/2006	CN1858224A Process preparing shark's fin polypeptide and use
11/08/2006	CN1858223A Process for preparing bitter gourd polypeptide and use
11/08/2006	CN1858222A Process for preparing sea cucumber polypeptide and use
11/08/2006	CN1858221A Process for preparing abalone polypeptide and use
11/08/2006	CN1283801C Protein expression in baculovirus vector expression system
11/08/2006	CN1283797C Process for microbial prodn. of amino acid by boosted activity of export carriers
11/08/2006	CN1283785C Method of producing human forcing erythrogenin using transgene animal mammary gland
11/08/2006	CN1283780C Method for constructing genetic engineering fungus of monascus with no citrinin
11/08/2006	CN1283778C Culture of Chansi mould strains and extraction and use of anagentic compound therefrom
11/08/2006	CN1283662C Antagonistic anti-hFAS ligand human antibodies and fragments thereof
11/08/2006	CN1283659C Truncated glial cell line-derived neurotrophic factor
11/08/2006	CN1283652C Isolated nucleic acid molecule encoding cancer associated antigen, antigen itself, and uses thereof
11/07/2006	US7132586 Protein production system
11/07/2006	US7132522 Regulatory sequences and expression cassettes for yeasts, especially for kluyveromyces
11/07/2006	US7132521 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
11/07/2006	US7132511 Modified anti-EGFR antibodies with reduced immunogenicity
11/07/2006	US7132510 Chimeric protein comprising immunogenic domains for directed targeting of tumor cells; immunotherapy; antitumor agents
11/07/2006	US7132509 Colon specific gene and protein
11/07/2006	US7132508 Mammalian chemokine reagents
11/07/2006	US7132507 Nucleotide sequences coding polypeptide for use in the treatment of cancer
11/07/2006	US7132429 Sulfonamido ether substituted imidazoquinolines
11/07/2006	US7132401 Beta-secretase substrates and uses thereof
11/07/2006	US7132399 Mammalian cell surface DNA receptor
11/07/2006	US7132396 Compositions which can be used for regulating the activity of parkin
11/07/2006	US7132395 Contacting human rhinovirus with a polypeptide having a fragment of human rhinovirus major receptor (HRR) permit HRV to bind to the polypeptide; HRV is inhibited from infecting host cell.
11/07/2006	US7132281 Methods and host cells for producing human monoclonal antibodies to CTLA-4
11/07/2006	US7132273 polynucleotides codes, cells transformed with genetic vectors and gene expression of heterologous polypeptides or proteins on the surfaces of cells; biochemical immobilization; biocatalysts; altering target protein characteristics such as binding affinity and stability by library screening
11/07/2006	US7132271 Methods for enhancing the production of viral vaccines in cell culture
11/07/2006	US7132270 Forms of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase
11/07/2006	US7132264 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis
11/07/2006	US7132263 Expression vectors comprising nucleotide sequences coding polypeptides which confer freeze resistance and tolerance; generation and propagation of cold tolerant crop plants
11/07/2006	US7132262 administering codon optimized polynucleotides that code human papillomavirus polypeptides comprising early proteins or fragments to cells of mammals; gene therapy; DNA vaccines
11/07/2006	US7132261 Nuclear localization peptides for estrogens; antitumor agents; anticarcinogenic agents; hormone replacement therapy; bradycardial agents
11/07/2006	US7132259 nucleic acids encoding neurotoxin polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; for biosynthesis of botulinum neurotoxins in host cells
11/07/2006	US7132255 drug screening for compounds that enhance or suppress killer T cell activity by contacting a population of killer T cells which express biliary glycoprotein with a compound that binds biliary glycoprotein and determining the cytotoxicity or proliferation of the killer T cells relative to a control
11/07/2006	US7132253 lowered activity for N-ethylglycine; reagent for measuring creatinine or creatine
11/07/2006	US7132248 Uses of galanin GALR2 receptors
11/07/2006	US7132234 or drug targets; contacting a poxviral p28 polypeptide with a candidate agent, and determining an effect on ubiquitin ligase activity of the p28; ubiquitylating a substrate by combining an E1 polypeptide, an E2 polypeptide, ubiquitin and a poxvirus P28 protein; variola virus (smallpox) drug discovery
11/07/2006	US7132101 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
11/07/2006	US7132099 Methods of modulating T lymphocyte costimulation with an antibody to an 8F4 polypeptide
11/07/2006	CA2128511C Monomeric and dimeric antibody-fragment fusion proteins
11/07/2006	CA2091967C Monoclonal anti-ganglioside antibody, its preparation and use as a tumor therapeutic agent
11/02/2006	WO2006116657A2 Single-chain antibody with cleavable linker
11/02/2006	WO2006116260A2 Modulation of antibody effector function by hinge domain engineering
11/02/2006	WO2006116182A1 Recombinant flavivirus vaccines
11/02/2006	WO2006113959A2 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein
11/02/2006	WO2006113957A2 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein
11/02/2006	WO2006043178A3 Enzymes
11/02/2006	WO2006036737A3 Methods for identifying new drug leads and new therapeutic uses for known drugs
11/02/2006	WO2005060479A3 Purified and isolated platelet calcium channel nucleic acids and polypeptides and therapeutic and screening methods using same
11/02/2006	WO2005004793A9 Compositions and methods for treating coagulation related disorders
11/02/2006	WO2004094790A3 Extendable/retractable support column
11/02/2006	US20060248616 Gene expression and production of TGF-beta proteins including bioactive mullerian inhibiting substance from plants
11/02/2006	US20060248605 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
11/02/2006	US20060248603 Novel fibrillin-like polypeptides
11/02/2006	US20060248602 Contacting polynucleotide with acetylthiourea, N,N-dimethylthioformamide, N,N'-diphenylthiourea, N-ethylthiourea, 2-imidazolidinethione, 4(6)-methyl-2-thiouracil, N-methylthiourea, phenylthio-carbamid, 6-phenyl-2-thiouracil, 6-propyl-2-thiouracil, tetramethylthiourea, thioacetamide, thioacetanilide
11/02/2006	US20060247425 Glycosylated immunoglobulin and immunoadhesin comprising the same
11/02/2006	US20060247424 Anti-idiotype antibody, method of constructing the anti-idiotype antibody, and method of preparing idiotype antibody using the anti-idiotype antibody
11/02/2006	US20060247421 Liver x receptor alpha splicing mutant protein, gene thereof and utilization of the same
11/02/2006	US20060247420 Immune cell recptor ligand and immune cell receptor
11/02/2006	US20060247419 Translocation dependent complementation for drug screening
11/02/2006	US20060247418 Gfp fusion proteins and their use
11/02/2006	US20060247198 TGF-beta type receptor cDNAs encoded products and uses therefor

1 ... 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 ... 1125